HOLX Stock Analysis: Buy, Sell, or Hold?

HOLX - Hologic Inc

X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
$75.55
-0.12 (-0.16%) ▼
5d: -0.12%
30d: +0.25%
90d: +1.41%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 07, 2026

Get Alerted When HOLX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: HOLX shows positive signals but monitor for confirmation. Market pricing in 3.5% growth. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$50.90
Based on -5.4% avg growth
INTRINSIC VALUE TODAY
$31.60
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: HOLX is currently trading at $75.55, which is considered slightly high relative to its 30-day fair value range of $75.23 to $75.62. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.0) compared to its historical average (18.0). At these levels, the market is pricing in 3.5% annual earnings growth.

Technical Outlook: Technically, HOLX is in a strong uptrend. The price is currently testing key support at $75.03. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: HOLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $75.23 - $75.62
Company Quality Score 64/100 (BUY)
Volume Confirmation HIGH
Confidence Score 74.8%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($76.67)
  • BULLISH: Expecting earnings turnaround to 3.5% growth with 2.5% revenue growth

Fair Price Analysis

30-Day Fair Range $75.23 - $75.62
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $75.03
Resistance Level $75.78
Current Trend Strong Uptrend
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 19.99
Wall Street Target $76.67 (+1.5%)
Revenue Growth (YoY) 2.5%
Earnings Growth (YoY) -9.2%
Profit Margin 13.2%
Valuation Premium vs History +3.5% premium
PE vs Historical 20.0 vs 18.0 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.5% (market-implied from PE analysis)
1-Year Target $78.19 (+4%)
2-Year Target $80.93 (+7%)
3-Year Target $83.76 (+11%)
3-Yr Target (if PE normalizes) (PE: 20→18) PE COMPRESSION $75.41 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: -14.8%) $61.57 (+-19%)
Base: (SPY PE: 20.0, Growth: -14.8%) $55.08 (-27%)
Bear: (PE: 17.0, Growth: -14.8%) $46.81 (-38%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 31.29 | Current EPS (TTM): $2.41
Bull Case $130.06 (+72%)
Analyst growth 56.8%, PE expands to 34.4
Base Case $118.23 (+56%)
Market implied 56.8%, PE stable at 31.3
Bear Case $51.28 (-32%)
Severe decline -20.0%, PE contracts to 26.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 31, 2026 12:07 AM ET
Data refreshes hourly during market hours. Next update: 1:07 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna SELL 2026-01-29
Ro Khanna SELL 2025-11-07
Ro Khanna SELL 2025-11-07

Unlock Insider Activity

See real-time buying/selling by company executives for HOLX.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$607 55 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$94 55 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$186 57 HOLD
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$318 63 BUY
AVTR
Avantor Inc
HOLD
21 analysts
$11 61 BUY

Advanced HOLX Option Strategies

Professional options setups generated by AI based on today's HOLX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for HOLX

HOLX Technical Chart HOLX Price Prediction HOLX Earnings Date HOLX Investment Advisor HOLX Fair Price Analyzer HOLX Options Advisor HOLX Options Chain HOLX Options Analysis HOLX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals